Labdanum

Labdanum (Cistus ladanifer / Cistus creticus): A Comprehensive Reference

1. Identity and Botanical Classification

1.1 Nomenclature

Labdanum, also called ladanum, ladan, or ladanon, is a sticky brown resin obtained from the shrubs Cistus ladanifer ("gum rockrose," western Mediterranean) and Cistus creticus ("pink rockrose," eastern Mediterranean), species of rock rose. The accepted botanical Latin name for the principal labdanum-producing plant species is Cistus ladanifer, belonging to the Cistaceae family. Cistus ladaniferus represents a historical synonym of the same species. The substance itself has historically carried several additional common names: it has been referred to as ladanon, black balsam, and gum cistus, all describing the same resinous product.

1.2 Botanical Source and Habitat

The plant is a resinous evergreen shrub found in Mediterranean scrubland and rocky areas. The species grows natively in the western Mediterranean region, particularly in Portugal, Spain, and southern France. The range of Cistus creticus, which supplies labdanum to eastern Mediterranean markets, includes the Greek islands, Crete, and the Levant. The plant is a Mediterranean shrub of growing interest due to its valuable essential oils and labdanum resin, with research emphasizing populations in Spain, Portugal, Morocco, and France.

Cistus ladanifer is a Mediterranean shrub traditionally used in folk medicine for treating respiratory, gastrointestinal, and skin ailments, and is now gaining scientific attention for its broader therapeutic and industrial potential.

1.3 The Resin: Physical Description and Natural Occurrence

Labdanum essential oil and resin come from Cistus ladanifer, a Mediterranean plant that produces a dark amber, sticky resin on its leaves and stems. The raw resin is plastic but not pourable, and becomes brittle with age. The absolute is dark amber-green and very thick at room temperature. The fragrance is more refined than the raw resin. The odour is very rich, complex, and tenacious.

1.4 Forms and Preparations

Labdanum is traded and used commercially in several distinct processed forms:

• Raw resin / oleoresin ("labdanum gum"): Registered under ECHA/REACH as "Gum of Cistus ladaniferus (Cistaceae) obtained from stems and leaves by extraction with alkaline solution." This is the traditional base material extracted by the Andalusian process (alkaline water followed by acid neutralisation) or the Zamorean process.
• Concrete: A "Concrete of Cistus ladaniferus (Cistaceae) obtained from stems and leaves by organic solvents extraction."
• Absolute / Resinoid: A "Resinoid of Cistus ladaniferus (Cistaceae) obtained from labdanum gum by ethanol extraction," which is in fact an ethanol labdanum absolute.
• Essential oil (cistus oil): Cistus essential oil is steam-distilled from the plant's leaves, while labdanum is solvent-extracted from the resinous leaves and twigs.
• Infusions and decoctions (tisanes): Infusions or decoctions prepared from shoots and leaves of C. ladanifer, sometimes referred to as labdanum tisanes, have traditionally been used to treat a wide range of ailments.

Commercial labdanum oil contains more than 300 constituents. Labdanum absolute represents approximately 70% of the raw resin; diterpenoid and flavonoid fractions represent approximately 75% and 15% of the absolute, respectively.

2. Traditional and Historical Use

2.1 Ancient Egypt and the Near East

Labdanum was one of the key ingredients used in kyphi, an ancient Egyptian incense blend burned in religious ceremonies and rituals as an offering to the gods and for its perceived spiritual and medicinal properties. In Ancient Greece, labdanum was considered an important ingredient in perfume, and was used in both incense and beauty products in Ancient Egypt. The ancient Greek physician Dioscorides stated that it was commonly used as an ingredient in "Royal Unguent," a topical semi-solid substance used for medicinal or cosmetic purposes.

Percy Newberry, a specialist on ancient Egypt, speculated that the false beard worn by Osiris and pharaohs may have originally represented a "labdanum-laden goat's beard." Archaeological evidence for the antiquity of the substance has been identified: a resinous archaeological sample from a tomb in Carthage (6th–5th century BC), housed in the Fragonard Museum (Grasse, France), was identified as labdanum, resin of the Cistus species.

Labdanum is also one of the main ingredients used in the Ketoret, an incense blend offering described in the Hebrew Bible. It is also referred to in the Bible as the Balm of Gilead. The Book of Genesis mentions labdanum being carried to Egypt from Canaan, consistent with the overland trade routes of the ancient Near East.

2.2 Classical Antiquity: Greece, Rome, and Arabia

Labdanum is thought to be one of the oldest aromatic materials used by the ancients. As described by Herodotus, the ancient Greek historian, the resin was first harvested from rockrose by Arabian shepherds who guided their goats into thickets of the shrub. Early Arab perfumers used labdanum in their recipes, describing it as "the sweetest-scented of all substances."

Labdanum was highly valued by ancient Egyptians, Greeks, and Romans, who used it for various purposes, including medicinal, cosmetic, and religious practices. It was often burned as incense in religious ceremonies and used in perfumes and ointments.

2.3 Traditional Harvesting Methods

In ancient times, labdanum was collected by combing the beards and thighs of goats and sheep that had grazed on the cistus shrubs. Wooden instruments used were referred to in 19th-century Crete as ergastiri; a lambadistrion ("labdanum-gatherer") was a kind of rake to which a double row of leathern thongs was fixed instead of teeth. These were used to sweep the shrubs and collect the resin, which was later extracted. It was collected by the shepherds and sold to coastal traders.

2.4 Traditional Medicinal Uses by Body System

The resin was used as an ingredient for incense, and medicinally to treat colds, coughs, menstrual problems, and rheumatism. Infusions or decoctions prepared from shoots and leaves of C. ladanifer, sometimes referred to as labdanum tisanes, have traditionally been used to treat a wide range of ailments, including gastrointestinal, respiratory, and nervous system disorders, mental illnesses, as well as metabolic conditions such as diabetes and hypertension. Folk medicine also associates C. ladanifer with the treatment of skin disorders and wound healing.

Its folk application as a medicinal plant is majorly related to its wound healing activity; its essential oil is used for wounds, skin ulcers, to stop haemorrhages, to avoid secondary infections, and for other skin ailments such as psoriasis and eczema. In addition to its application to treat superficial wounds, its antiseptic use is also reported in ethnopharmacological studies.

These extracts have been used in traditional medicine since ancient times to treat various health issues like skin diseases, diarrhoea, dysentery, menstruation discomfort, and catarrh.

Ethnobotanical reports describe its use for medicinal purposes in managing hyperglycaemia and mental illnesses, although data concerning bioactivities and pharmacological applications remain scarce.

2.5 Traditional Use in Perfumery

Labdanum is much valued in perfumery because of its resemblance to ambergris, which has been banned from use in many countries because it originates from the sperm whale, which is an endangered species. Labdanum is the main ingredient used when making the scent of amber in perfumery, as well as chypre fragrances. It was historically used in herbal medicine and is still used in the preparation of some perfumes and vermouths.

3. Key Constituents and Phytochemistry

3.1 Major Chemical Classes

Phytochemical investigations have revealed that C. ladanifer is rich in secondary metabolites, particularly phenolic acids, flavonoids, and terpenes — both monoterpene and sesquiterpene derivatives — which are responsible for its potent antioxidant, antimicrobial, anti-inflammatory, and anti-cancer properties.

Labdanum absolute represents approximately 70% of the raw resin; diterpenoid and flavonoid fractions represent approximately 75% and 15% of the absolute, respectively. Labdane-type diterpenoids and methylated flavonoids are the main compounds in labdanum absolute and in the diterpenoid and flavonoid fractions, respectively.

GC-EI-MS analysis has confirmed the presence of phenylpropanoids, labdane-type diterpenoids, and methylated flavonoids, which are already described in the literature, alongside other compounds, with different extracts presenting distinct chemical profiles.

3.2 Essential Oil Constituents

α-Pinene, viridiflorol, and camphene are the major constituents in the essential oils of C. ladanifer, with antioxidant and antimicrobial properties. Some Portuguese-grown samples exhibit a different chemical composition characterised by the predominance of viridiflorol (20–22.6%), ledol (6.4–6.7%), and trans-pinocarveol (5.4–8.6%).

3.3 Resin Phenolic and Terpenoid Constituents

Chemical fractionation of labdanum absolute has revealed it to comprise approximately 22.3% free acids, 37.5% phenols, and 44.2% neutral compounds. The resinoid and concrete of C. ladanifer are found to be rich in waxes and high-molecular-weight hydrocarbons. The main identified compounds of other extracts are compounds derived from labdane and alpha-labdene skeletal frameworks.

Labdane-type diterpenes represent the major pharmaceutically active components of C. ladanifer resin, exhibiting antimicrobial, anti-inflammatory, and immune-modulating effects, as well as cytotoxic activity against leukaemia cells by affecting apoptosis, cell cycle regulation, and the expression of proto-oncogenes such as c-myc and bcl-2.

Flavonoids, particularly methylated derivatives such as kaempferol-3,7-dimethyl ether (jaranol), also contribute significantly to the biological properties of labdanum. Environmental stressors typical of the Mediterranean climate — high UV radiation and drought — enhance both resin secretion and the accumulation of methylated flavonoids.

Other polyphenols identified in plant tissues include kaempferol, punicalagingallate, punicalin, punicalagin, epigallocatechin, ellagic acid, gallic acid, myricitrin, and quercetin.

4. Proposed Mechanisms of Action

4.1 Anti-inflammatory Mechanisms

Labdanum enriched with apigenin and kaempferol-based flavonoids exhibits strong anti-inflammatory and antioxidant effects, notably by inhibiting nitric oxide release in LPS-stimulated RAW 264.7 macrophages. Inhibition of nitric oxide production is a well-established in vitro proxy for suppression of inflammatory signalling through the iNOS pathway. Additionally, anti-aging and anti-inflammatory activity have been reported by the inhibition of elastase activity (22% and 13%, by absolute and flavonoid extract at 1 mg/mL), and by the inhibition of nitric oxide production in LPS-induced RAW 264.7 cells (84% to 98%, at 15 µg/mL extracts, flavonoid fraction the most active).

4.2 Antimicrobial Mechanisms

The low density of plant oils and their rapid diffusion across cell membranes due to their hydrophobicity may support non-specific inhibition by disturbing ATPase efficiency or the proton motor force, thus blocking cell division. Against fungi, the capacity of labdanum essential oil to suppress aflatoxin B1 production suggests a mode of action based on inhibition of ergosterol biosynthesis — the basic sterol of the fungal cell membrane — and enhancement of ion leakage from fungal cells, which leads to fungal growth inhibition.

4.3 Antidiabetic (Enzyme Inhibition) Mechanisms

The potential antidiabetic activity has been investigated by inhibition of α-amylase and α-glucosidase — enzymes relevant in the management of type 2 diabetes mellitus by reducing carbohydrate breakdown and subsequent absorption.

4.4 Neuroprotective (Acetylcholinesterase Inhibition) Mechanisms

Given the documented traditional use of Cistus spp. to control nervous system and mental disorders, the inhibitory action of C. ladanifer labdanum on acetylcholinesterase (AChE) activity is of particular relevance, as cholinesterase inhibition is a current therapeutic strategy for neurodegenerative conditions.

4.5 UV-Protective Mechanisms

Labdanum absolute showed a spectrophotometric sun protection factor (SPF) near 5, which is mainly attributable to flavonoids, as the flavonoids' SPF was 13. Significant absorbance of UVA radiation has been demonstrated in labdanum absolute, with flavonoids responsible for that feature, whereas the diterpenoid fraction's contribution is very low or negligible, directly correlating with the chemical structures of the compounds.

5. Scientific Evidence by Area of Use

5.1 Anti-inflammatory and Analgesic Activity

The most robust preclinical evidence for labdanum as an anti-inflammatory and analgesic agent comes from in vivo animal studies. A study published in 2022 (Adadi et al., Journal of Pharmaceutical and Biomedical Analysis) specifically investigated the phytochemical profile and therapeutic effects of aqueous extract of C. ladanifer aerial parts (AECL): the study investigated the phytochemical profile, the in vivo anti-inflammatory, and the wound healing activities of the aqueous extract from the aerial parts (AECL), with the in vivo anti-inflammatory and wound healing properties evaluated by carrageenan-induced paw oedema and burn wound in rats, respectively. The results showed that six compounds belonging to flavonoids and tannins were identified in the AECL extract. The AECL administered orally at a dose of 500 mg/kg significantly reduced oedema with an inhibition percentage of 72%, using indomethacin as the reference drug. When administered topically, both doses of CAECL cream (5% and 10%) manifested a significant anti-inflammatory action using diclofenac as the reference drug, with a percentage reduction of inflammation reaching 85% at the 10% concentration.

An earlier study designed to evaluate the analgesic and anti-inflammatory activities of aqueous extract of C. ladanifer leaves in experimental animal models used the hot plate method in rats and the carrageenan-induced paw oedema model. The results showed that the aqueous extract of C. ladanifer exhibited anti-inflammatory and analgesic effects in a dose-dependent manner, with the extract at all doses significantly reducing the paw inflammation oedema after carrageenan injection.

Evidence strength: All anti-inflammatory and analgesic evidence is preclinical (animal models). No human clinical trials have been identified. The data are preliminary and cannot be extrapolated directly to clinical practice.

5.2 Wound Healing

As for wound healing, the topical CAECL cream showed higher effect at a dose of 10% (CAECL-10), producing a wound contraction of 96%, similar to that of the reference drug. The findings indicate that the aqueous extract from aerial parts of Cistus ladanifer L. displays strongly anti-inflammatory and wound healing effects.

Evidence strength: Preclinical only (rat burn wound model). No human studies exist. This aligns with long-standing ethnobotanical use of the plant for skin wounds and ulcers, but no controlled clinical trial data are available.

5.3 Antimicrobial Activity

Multiple in vitro laboratory studies have assessed labdanum and C. ladanifer extracts against clinically relevant organisms:

• Antimicrobial activity against relevant skin and cosmetic product microorganisms — Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, and Escherichia coli — revealed that only S. aureus was susceptible to labdanum absolute (MIC: 1.2 mg/mL) and its fractions (MIC: <0.3 mg/mL).
• C. ladanifer extracts showed antimicrobial activity against several Gram-positive and Gram-negative bacteria strains, pathogenic yeast, and fungi. Aqueous extracts from this plant also possess anti-inflammatory and anti-nociceptive activities in vivo.
• Against Staphylococcus species specifically, Guinoiseau demonstrated the potential of C. ladaniferus essential oil and its efficacy against tested strains, ranging from 0.012 mg/mL for the acetate fraction to 0.8 mg/mL for the essential oil, in coordination with inhibition zones. Alcohol fraction led to 99.9% inhibition in less than one hour, with action achieved without cell lysis or drastic cell wall damage.
• The C. ladanifer leaf oil was the most efficient inhibitory labdanum material tested on various strains, followed by the concrete and the absolute. Labdanum resinoid exhibited the least efficacy.

In conclusion, labdanum resin showed potential to be used in sunscreen cosmetics and anti-inflammatory skincare cosmeceuticals or medicines, but has low potential as a cosmetic product preservative given the low antioxidant and low-spectrum antimicrobial activities.

Evidence strength: All antimicrobial evidence is in vitro. Spectrum of activity appears narrow; most Gram-negative organisms are resistant at achievable concentrations. No human clinical trials. Findings are hypothesis-generating only.

5.4 Skin Photoprotection and Cosmeceutical Activity

A 2022 study published in Plants (Basel) (Frazão et al., PMID 35684251) used UPLC-DAD-ESI-MS to characterise labdanum methanolic absolute and fractions, then evaluated their UV-protection, antioxidant, anti-elastase, anti-inflammatory, and antimicrobial activities: aiming to evaluate the skincare potential, labdanum methanolic absolute and fractions purified by column chromatography were characterised by UPLC-DAD-ESI-MS and then evaluated for UV-protection, antioxidant, anti-elastase, anti-inflammatory, and antimicrobial activities. Labdanum absolute represented approximately 70% of the resin; diterpenoid and flavonoid fractions represented approximately 75% and 15% of the absolute, respectively. Labdane-type diterpenoids and methylated flavonoids were the main compounds in the absolute and respective fractions.

Low antioxidant activity was observed overall, with ABTS radical scavenging being the most significant (0.142 ± 0.017 mgTE/mgExt for the absolute; 0.379 ± 0.039 mgTE/mgExt for the flavonoid fraction; 0.010 ± 0.003 mgTE/mgExt for the terpene fraction).

Evidence strength: All skincare evidence is in vitro (cell-line and spectrophotometric assays). There are no published randomised controlled trials in human volunteers or patients. Findings suggest cosmeceutical potential, particularly for the flavonoid fraction, but remain preliminary.

5.5 Antidiabetic Potential

A 2024 study published in Molecules (MDPI, PMID 38792084; Frazão et al.) investigated labdanum's antidiabetic potential for the first time: the potential antidiabetic activity was investigated by inhibition of α-amylase and α-glucosidase. The diterpenoid fraction produced the higher α-amylase inhibitory effect (approximately 30% and 40% at 0.5 and 1 mg/mL, respectively). The Zamorean absolute showed the highest α-glucosidase inhibitory effect (approximately 14% and 24%, at 0.5 and 1 mg/mL, respectively).

The authors showed for the first time that labdanum resin has antidiabetic and neuroprotective properties, and identified a range of safe concentrations that can be considered when using it orally for medicinal purposes. This study establishes a starting point for future studies using more complex in vitro and in vivo models, aiming to develop new pharmaceutical formulations based on this natural resource.

Evidence strength: In vitro enzyme inhibition assay only. No animal or human studies specifically on labdanum resin for diabetes management have been published. This is very early-stage, hypothesis-generating research.

5.6 Neuroprotective Potential (Acetylcholinesterase Inhibition)

In the same 2024 Molecules study: the Andalusian absolute showed the highest acetylcholinesterase inhibitory effect (approximately 70% and 75%, at 0.5 and 1 mg/mL, respectively). This degree of AChE inhibition in vitro is notable, as AChE inhibition is the principal pharmacological strategy used by approved drugs for Alzheimer's disease (e.g., donepezil). However, direct equivalence cannot be drawn from in vitro enzyme assay data to clinical drug effect.

Evidence strength: In vitro only. No animal or human studies. Mechanistic relevance to neurodegenerative disease requires substantial further investigation.

5.7 Anti-proliferative / Cytotoxic Activity

Using Caco-2 (colon carcinoma) and HepG2 (hepatocellular carcinoma) cell lines, the Andalusian absolute and its purified fractions showed moderate cytotoxic/anti-proliferative activity at 24-hour exposure (IC₅₀ = 45–70 µg/mL for Caco-2; IC₅₀ = 60–80 µg/mL for HepG2), whereas the Zamorean absolute did not produce cytotoxicity (IC₅₀ ≥ 200.00 µg/mL).

Labdane-type diterpenes have been reported to exhibit cytotoxic activity against leukaemia cells by affecting apoptosis, cell cycle regulation, and the expression of proto-oncogenes such as c-myc and bcl-2.

Evidence strength: In vitro cell-line studies only. The cytotoxic concentrations observed in Caco-2 and HepG2 cells are in the moderate range and are far from constituting clinical evidence of anticancer activity in any human context. No animal models or clinical trials exist.

5.8 Antioxidant Activity

It was reported that C. ladanifer is a source of natural antioxidants that can be exploited in the food or cosmetic industry given the high levels of existing flavonoids and phenolic compounds. However, the quantitative results from fractionated labdanum absolute are modest: low antioxidant activity was observed overall, with ABTS radical scavenging being the most significant parameter. The flavonoid fraction consistently outperforms the diterpenoid fraction in antioxidant assays.

Evidence strength: In vitro only (DPPH, ABTS assays). Relevance to systemic antioxidant capacity in humans is not established. No human trials.

6. Body Systems and Health Areas of Association

• Integumentary System (Skin): Traditionally used for wound healing and fragrance, labdanum absolute has demonstrated UV-protective, anti-inflammatory, and selective antimicrobial properties, emphasising its relevance as a sustainable component in skincare and cosmetic applications.
• Respiratory System: Historically used medicinally to treat colds and coughs.
• Musculoskeletal System: Historically used to treat rheumatism.
• Reproductive / Gynaecological: Traditionally employed to address menstrual problems.
• Gastrointestinal System: Traditional use includes gastrointestinal disorders, including diarrhoea and dysentery.
• Metabolic / Endocrine (Diabetes): C. ladanifer shows significant promise in managing chronic conditions such as diabetes, though only in vitro enzyme inhibition data currently support this.
• Nervous System: Nervous system disorders and mental illnesses have been traditional indications. Preliminary in vitro evidence of acetylcholinesterase inhibition provides a mechanistic candidate, but no clinical data exist.
• Immune System: In natural medicine, labdanum has been prescribed to boost the immune system. No controlled clinical evidence exists.

7. Dosage Forms and Dosages Reported in Studies

There are no standardised therapeutic dosages established for labdanum in any pharmacopoeia or regulatory monograph. The following are dosages specifically as reported in identified primary research:

• Oral administration (anti-inflammatory, animal model): The aqueous extract (AECL) administered orally at a dose of 500 mg/kg significantly reduced oedema with a percentage of 72% in terms of inflammation inhibition.
• Topical cream (anti-inflammatory and wound healing, animal model): Topical doses of CAECL cream at 5% and 10% manifested significant anti-inflammatory action, with 85% reduction of inflammation at the 10% concentration; wound contraction reached 96% at the 10% dose.
• In vitro anti-elastase (skin cosmeceutical): Inhibition of elastase activity was measured at 22% and 13%, by the absolute and flavonoid extract respectively, at 1 mg/mL.
• In vitro anti-inflammatory (nitric oxide inhibition): Inhibition of nitric oxide production in LPS-induced RAW 264.7 cells was 84% to 98% at 15 µg/mL extracts.
• In vitro antidiabetic (α-amylase inhibition): The diterpenoid fraction produced approximately 30% and 40% α-amylase inhibitory effect at 0.5 and 1 mg/mL, respectively.
• In vitro neuroprotective (AChE inhibition): The Andalusian absolute showed approximately 70% and 75% acetylcholinesterase inhibitory effect at 0.5 and 1 mg/mL, respectively.
• Acute oral toxicity test (animal): Male and female mice were orally administered the aqueous extract at single doses of 500, 1000, 2000, 3000, and 5000 mg/kg.

Labdanum and Cistus ladanifer products vary widely in strength, purity, and intended use, and human dosing is not well standardised.

8. Safety Considerations

8.1 Regulatory Status of the Resin

There are three ECHA registrations (REACH regulation) for labdanum resin with a complete chemical safety assessment, covering the raw gum, the concrete, and the ethanol absolute. All these registered substances are reported to have no physical, environmental, and human health hazards, which includes a complete toxicological assessment. However, further toxicological and/or skin irritation tests may be necessary to ensure the safety of using labdanum resin, or its flavonoid and terpenoid fractions, as a whole or in part as cosmetic ingredients, in order to guarantee complete consumer safety.

8.2 Acute and Subchronic Toxicology

During an acute toxicity test, when mice were administered doses of 3000 and 5000 mg/kg, the C. ladanifer aqueous extract produced a 10% to 30% mortality rate, respectively, and induced signs of toxicity. However, no mortality or adverse effect was noted at the doses of 1000 and 2000 mg/kg. The median lethal dose (LD₅₀) of the extract was estimated to be more than 5000 mg/kg.

In the subchronic study, the extract induced no mortality or treatment-related adverse effects with regard to body weight, general behaviour, relative organ weights, urine, haematological, and biochemical parameters. These findings are consistent with broader ethnobotanical observations: informants reported that all uses of C. ladanifer were effective and caused no side effects, consistent with toxicological data: sub-chronic oral administration of aqueous leaf extracts in rats caused no significant effects on body weight, behaviour, organ weights, or blood parameters, except at very high doses. Oral administration in rats at moderate doses induced no clinical, biochemical, or histopathological changes, confirming the safety of the extracts in traditional use.

8.3 Hepatotoxicity Risk at High Doses

The aqueous extract at both moderate doses and the methanolic extract at 150 mg/kg did not produce any biochemical or histological alterations. However, the methanolic extract showed hepatic toxicity at 300 mg/kg. This suggests that while aqueous preparations (teas, decoctions) are well tolerated in animal models, more concentrated solvent-derived extracts may carry hepatotoxic risk at elevated doses. Toxic side-effects must also be addressed when using these products by ingestion, as done traditionally.

8.4 Cytotoxicity Dependent on Extraction Method

Using Caco-2 and HepG2 cell lines, the Andalusian absolute and its purified fractions showed moderate cytotoxic/anti-proliferative activity at 24-hour exposure (IC₅₀ = 45–70 µg/mL for Caco-2; IC₅₀ = 60–80 µg/mL for HepG2), whereas Zamorean absolute did not produce cytotoxicity (IC₅₀ ≥ 200.00 µg/mL). This underscores that the extraction process materially affects both bioactivity and safety profile.

8.5 Skin Safety and Allergenicity

All REACH-registered labdanum substances are reported to have no physical, environmental, and human health hazards in their complete toxicological assessment. However, further skin irritation tests may be necessary to ensure the safety of using labdanum resin or its fractions as cosmetic ingredients to guarantee complete consumer safety. No clinical data from patch-testing studies in sensitised human populations have been identified for labdanum specifically, though resinous plant materials as a class carry some potential for contact sensitisation.

8.6 FDA Status

Cistus essential oil is approved by the Food and Drug Administration (FDA) as a food additive and flavouring agent, and is also taken as a dietary supplement. This approval pertains to the essential oil and flavouring use, not to therapeutic claims for the labdanum resin.

8.7 Evidence Gaps and Limitations

While its rich, amber-like aroma captivates the senses, labdanum's therapeutic potential remains largely unexplored by modern science. The current body of scientific literature on labdanum as a therapeutic agent consists overwhelmingly of in vitro assays and rodent models; no published randomised controlled trials in humans have been identified for any indication. All mechanistic claims — antimicrobial, anti-inflammatory, antidiabetic, neuroprotective, and anti-proliferative — are based on preclinical data, and none have been confirmed in well-designed human clinical trials.

References

• Frazão DF et al. (2022). Labdanum Resin from Cistus ladanifer L.: A Natural and Sustainable Ingredient for Skin Care Cosmetics with Relevant Cosmeceutical Bioactivities. Plants (Basel), 11(11):1477. PMC9183103.
• Frazão DF et al. (2024). Labdanum Resin from Cistus ladanifer L. as a Source of Compounds with Anti-Diabetic, Neuroprotective and Anti-Proliferative Activity. Molecules, 29(10):2222. PMC11124373.
• Adadi I et al. (2022). Phytochemical profile, in vivo anti-inflammatory and wound healing activities of the aqueous extract from aerial parts of Cistus ladanifer L. Journal of Pharmaceutical and Biomedical Analysis. PubMed PMID 35914506.
• El Youbi AEH et al. (2016). In Vivo Anti-Inflammatory and Analgesic Effects of Aqueous Extract of Cistus ladanifer L. From Morocco. American Journal of Therapeutics. PubMed PMID 26934730.
• Gaweł-Bęben K et al. (2020). Characterization of Cistus × incanus L. and Cistus ladanifer L. Extracts as Potential Multifunctional Antioxidant Ingredients for Skin Protecting Cosmetics. Antioxidants (Basel), 9(3):202. PMC7139296.
• Teixeira S et al. (2021). A Review on Cistus sp.: Phytochemical and Antimicrobial Activities. PMC8232106.
• Alves-Ferreira J et al. (2025). Cistus ladanifer L.: Essential Oils, Volatiles, By-Products, and Their Biological Properties. Molecules, 30(22):4425.
• Springer Nature (2026). Cistus ladanifer comprehensive update on ethnopharmacology, chemical profile and biological activities from 2020 to 2024. Discover Plants.
• El Kabbaoui M et al. (2017). Acute and sub-chronic toxicity studies of the aqueous extract from leaves of Cistus ladaniferus L. in mice and rats. Journal of Ethnopharmacology, 209:147–156.
• Wikipedia. Labdanum (accessed 2025).
• Greche H et al. Chemical composition, antibacterial and antifungal activities of Moroccan Cistus ladanifer L. leaves extracts. ResearchGate.
• Ethnobotany Research and Applications (2025). Ethnobotany of Cistus ladanifer L.: An important traditional medicinal plant.
• The Perfume Society. Labdanum ingredient profile.
• ScienceDirect Topics. Cistus ladanifer — an overview.